https://www.selleckchem.com/pr....oducts/bso-l-buthion
9% vs. 4.3%, P 0.001; BB 5.4% vs. 0.7%, P = 0.004), while the O1O1 genotype was significantly less frequent in patients (24.3% vs. 37.3%, P = 0.036). Analyzing the severity of the clinical presentation according to the PESI score, we did not find acorrelation between the severity of the clinical presentation and acertain blood type genotype. Patients with A1B and BB blood type genotype were at increased risk for developing pulmonary embolism, while patients with O1O1 genotype had asignificantly lower risk o